Pierluigi Paracchi

Pierluigi Paracchi

Chief Executive Officer at GENENTA SCIENCE S.P.A.

Net worth: 2 M $ as of 31/05/2026

52 year
Health Technology
Finance
Consumer Services

Profile

Pierluigi Paracchi was the founder of Xyence Capital SGR SpA, founded in 2003, where the title held was Chief Executive Officer from 2009 to 2011.
Mr. Paracchi is the founder of Genenta Science SpA, founded in 2014, holding the title of Chairman & Chief Executive Officer starting in 2024.
Mr. Paracchi is the founder of Aurora-TT Srl, founded in 2017, with the title of Venture Consultant starting in 2017.
Mr. Paracchi is also the founder of Aurora Science Srl..
Mr. Paracchi is Chairman & Chief Executive Officer at Praexidia Industrie Strategiche SpA starting in 2025.
Mr. Paracchi is Director at Assobiotec starting in 2019.
Mr. Paracchi is Director at Altheia Science Srl.
Former positions include Non-Executive Chairman at Lipogems International SpA, Director at EOS SpA, and Venture Partner at Axon Partners Group Investment SGEIC SA. Education includes undergraduate studies at Università Cattolica del Sacro Cuore Campus di Milano.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/03/2026 2,302,516 ( 12.64% ) 2 M $ 31/05/2026

Pierluigi Paracchi active positions

CompaniesPositionStart
GENENTA SCIENCE S.P.A. Chief Executive Officer 24/07/2014
Founder 01/01/2017
Director/Board Member -
Director/Board Member 15/05/2019

Former positions of Pierluigi Paracchi

CompaniesPositionEnd
Founder 01/02/2011
Private Equity Investor -
Chairman -
Founder -
Director/Board Member -
See the detail of Pierluigi Paracchi's experience

Training of Pierluigi Paracchi

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

16

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Consumer Services

Finance

Health Technology

Finance

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Finance

  1. Stock Market
  2. Insiders
  3. Pierluigi Paracchi